Global Poliomyelitis Vaccine Market Insights, Forecast to 2029

SKU ID : QYR-23882798 | Publishing Date : 26-May-2023 | No. of pages : 88

Request a free Sample

Detailed TOC of Global Poliomyelitis Vaccine Market Insights, Forecast to 2029

1 Study Coverage
    1.1 Poliomyelitis Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Poliomyelitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
        1.2.2 Poliomyelitis Vaccine Ⅰ
        1.2.3 Poliomyelitis Vaccine Ⅱ
        1.2.4 Poliomyelitis Vaccine Ⅲ
        1.2.5 Oral Poliomyelitis Vaccine
    1.3 Market by Application
        1.3.1 Global Poliomyelitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
        1.3.2 VAPP
        1.3.3 VDPV
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Executive Summary
    2.1 Global Poliomyelitis Vaccine Sales Estimates and Forecasts 2018-2029
    2.2 Global Poliomyelitis Vaccine Revenue by Region
        2.2.1 Global Poliomyelitis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
        2.2.2 Global Poliomyelitis Vaccine Revenue by Region (2018-2023)
        2.2.3 Global Poliomyelitis Vaccine Revenue by Region (2024-2029)
        2.2.4 Global Poliomyelitis Vaccine Revenue Market Share by Region (2018-2029)
    2.3 Global Poliomyelitis Vaccine Sales Estimates and Forecasts 2018-2029
    2.4 Global Poliomyelitis Vaccine Sales by Region
        2.4.1 Global Poliomyelitis Vaccine Sales by Region: 2018 VS 2022 VS 2029
        2.4.2 Global Poliomyelitis Vaccine Sales by Region (2018-2023)
        2.4.3 Global Poliomyelitis Vaccine Sales by Region (2024-2029)
        2.4.4 Global Poliomyelitis Vaccine Sales Market Share by Region (2018-2029)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
    3.1 Global Poliomyelitis Vaccine Sales by Manufacturers
        3.1.1 Global Poliomyelitis Vaccine Sales by Manufacturers (2018-2023)
        3.1.2 Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2018-2023)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poliomyelitis Vaccine in 2022
    3.2 Global Poliomyelitis Vaccine Revenue by Manufacturers
        3.2.1 Global Poliomyelitis Vaccine Revenue by Manufacturers (2018-2023)
        3.2.2 Global Poliomyelitis Vaccine Revenue Market Share by Manufacturers (2018-2023)
        3.2.3 Global Top 10 and Top 5 Companies by Poliomyelitis Vaccine Revenue in 2022
    3.3 Global Key Players of Poliomyelitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    3.4 Global Poliomyelitis Vaccine Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Poliomyelitis Vaccine, Product Offered and Application
    3.8 Global Key Manufacturers of Poliomyelitis Vaccine, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Poliomyelitis Vaccine Sales by Type
        4.1.1 Global Poliomyelitis Vaccine Historical Sales by Type (2018-2023)
        4.1.2 Global Poliomyelitis Vaccine Forecasted Sales by Type (2024-2029)
        4.1.3 Global Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    4.2 Global Poliomyelitis Vaccine Revenue by Type
        4.2.1 Global Poliomyelitis Vaccine Historical Revenue by Type (2018-2023)
        4.2.2 Global Poliomyelitis Vaccine Forecasted Revenue by Type (2024-2029)
        4.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    4.3 Global Poliomyelitis Vaccine Price by Type
        4.3.1 Global Poliomyelitis Vaccine Price by Type (2018-2023)
        4.3.2 Global Poliomyelitis Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
    5.1 Global Poliomyelitis Vaccine Sales by Application
        5.1.1 Global Poliomyelitis Vaccine Historical Sales by Application (2018-2023)
        5.1.2 Global Poliomyelitis Vaccine Forecasted Sales by Application (2024-2029)
        5.1.3 Global Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    5.2 Global Poliomyelitis Vaccine Revenue by Application
        5.2.1 Global Poliomyelitis Vaccine Historical Revenue by Application (2018-2023)
        5.2.2 Global Poliomyelitis Vaccine Forecasted Revenue by Application (2024-2029)
        5.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    5.3 Global Poliomyelitis Vaccine Price by Application
        5.3.1 Global Poliomyelitis Vaccine Price by Application (2018-2023)
        5.3.2 Global Poliomyelitis Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
    6.1 US & Canada Poliomyelitis Vaccine Market Size by Type
        6.1.1 US & Canada Poliomyelitis Vaccine Sales by Type (2018-2029)
        6.1.2 US & Canada Poliomyelitis Vaccine Revenue by Type (2018-2029)
    6.2 US & Canada Poliomyelitis Vaccine Market Size by Application
        6.2.1 US & Canada Poliomyelitis Vaccine Sales by Application (2018-2029)
        6.2.2 US & Canada Poliomyelitis Vaccine Revenue by Application (2018-2029)
    6.3 US & Canada Poliomyelitis Vaccine Market Size by Country
        6.3.1 US & Canada Poliomyelitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        6.3.2 US & Canada Poliomyelitis Vaccine Sales by Country (2018-2029)
        6.3.3 US & Canada Poliomyelitis Vaccine Revenue by Country (2018-2029)
        6.3.4 US
        6.3.5 Canada
7 Europe
    7.1 Europe Poliomyelitis Vaccine Market Size by Type
        7.1.1 Europe Poliomyelitis Vaccine Sales by Type (2018-2029)
        7.1.2 Europe Poliomyelitis Vaccine Revenue by Type (2018-2029)
    7.2 Europe Poliomyelitis Vaccine Market Size by Application
        7.2.1 Europe Poliomyelitis Vaccine Sales by Application (2018-2029)
        7.2.2 Europe Poliomyelitis Vaccine Revenue by Application (2018-2029)
    7.3 Europe Poliomyelitis Vaccine Market Size by Country
        7.3.1 Europe Poliomyelitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        7.3.2 Europe Poliomyelitis Vaccine Sales by Country (2018-2029)
        7.3.3 Europe Poliomyelitis Vaccine Revenue by Country (2018-2029)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia
8 China
    8.1 China Poliomyelitis Vaccine Market Size
        8.1.1 China Poliomyelitis Vaccine Sales  (2018-2029)
        8.1.2 China Poliomyelitis Vaccine Revenue  (2018-2029)
    8.2 China Poliomyelitis Vaccine Market Size by Application
        8.2.1 China Poliomyelitis Vaccine Sales by Application (2018-2029)
        8.2.2 China Poliomyelitis Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
    9.1 Asia Poliomyelitis Vaccine Market Size by Type
        9.1.1 Asia Poliomyelitis Vaccine Sales by Type (2018-2029)
        9.1.2 Asia Poliomyelitis Vaccine Revenue by Type (2018-2029)
    9.2 Asia Poliomyelitis Vaccine Market Size by Application
        9.2.1 Asia Poliomyelitis Vaccine Sales by Application (2018-2029)
        9.2.2 Asia Poliomyelitis Vaccine Revenue by Application (2018-2029)
    9.3 Asia Poliomyelitis Vaccine Sales by Region
        9.3.1 Asia Poliomyelitis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
        9.3.2 Asia Poliomyelitis Vaccine Revenue by Region (2018-2029)
        9.3.3 Asia Poliomyelitis Vaccine Sales by Region (2018-2029)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India
10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Poliomyelitis Vaccine Market Size by Type
        10.1.1 Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Type (2018-2029)
        10.1.2 Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Type (2018-2029)
    10.2 Middle East, Africa and Latin America Poliomyelitis Vaccine Market Size by Application
        10.2.1 Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Application (2018-2029)
        10.2.2 Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Application (2018-2029)
    10.3 Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Country
        10.3.1 Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        10.3.2 Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Country (2018-2029)
        10.3.3 Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Country (2018-2029)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Company Information
        11.1.2 GSK Overview
        11.1.3 GSK Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.1.4 GSK Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 Sanofi-Pasteur
        11.2.1 Sanofi-Pasteur Company Information
        11.2.2 Sanofi-Pasteur Overview
        11.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi-Pasteur Recent Developments
    11.3 Merck
        11.3.1 Merck Company Information
        11.3.2 Merck Overview
        11.3.3 Merck Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.3.4 Merck Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Crucell
        11.4.1 Crucell Company Information
        11.4.2 Crucell Overview
        11.4.3 Crucell Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.4.4 Crucell Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Crucell Recent Developments
    11.5 China National Biotech Group
        11.5.1 China National Biotech Group Company Information
        11.5.2 China National Biotech Group Overview
        11.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.5.4 China National Biotech Group Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 China National Biotech Group Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Information
        11.6.2 Eli Lilly Overview
        11.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.6.4 Eli Lilly Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Eli Lilly Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Poliomyelitis Vaccine Industry Chain Analysis
    12.2 Poliomyelitis Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Poliomyelitis Vaccine Production Mode & Process
    12.4 Poliomyelitis Vaccine Sales and Marketing
        12.4.1 Poliomyelitis Vaccine Sales Channels
        12.4.2 Poliomyelitis Vaccine Distributors
    12.5 Poliomyelitis Vaccine Customers
13 Market Dynamics
    13.1 Poliomyelitis Vaccine Industry Trends
    13.2 Poliomyelitis Vaccine Market Drivers
    13.3 Poliomyelitis Vaccine Market Challenges
    13.4 Poliomyelitis Vaccine Market Restraints
14 Key Findings in The Global Poliomyelitis Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Figures, Tables and Charts Available in Global Poliomyelitis Vaccine Market Insights, Forecast to 2029

List of Tables
    Table 1. Global Poliomyelitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Poliomyelitis Vaccine Ⅰ
    Table 3. Major Manufacturers of Poliomyelitis Vaccine Ⅱ
    Table 4. Major Manufacturers of Poliomyelitis Vaccine Ⅲ
    Table 5. Major Manufacturers of Oral Poliomyelitis Vaccine
    Table 6. Global Poliomyelitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Poliomyelitis Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Poliomyelitis Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 9. Global Poliomyelitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 10. Global Poliomyelitis Vaccine Revenue Market Share by Region (2018-2023)
    Table 11. Global Poliomyelitis Vaccine Revenue Market Share by Region (2024-2029)
    Table 12. Global Poliomyelitis Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 13. Global Poliomyelitis Vaccine Sales by Region (2018-2023) & (K Units)
    Table 14. Global Poliomyelitis Vaccine Sales by Region (2024-2029) & (K Units)
    Table 15. Global Poliomyelitis Vaccine Sales Market Share by Region (2018-2023)
    Table 16. Global Poliomyelitis Vaccine Sales Market Share by Region (2024-2029)
    Table 17. Global Poliomyelitis Vaccine Sales by Manufacturers (2018-2023) & (K Units)
    Table 18. Global Poliomyelitis Vaccine Sales Share by Manufacturers (2018-2023)
    Table 19. Global Poliomyelitis Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 20. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2018-2023)
    Table 21. Global Key Players of Poliomyelitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 22. Poliomyelitis Vaccine Price by Manufacturers 2018-2023 (USD/Unit)
    Table 23. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
    Table 25. Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Poliomyelitis Vaccine, Product Offered and Application
    Table 27. Global Key Manufacturers of Poliomyelitis Vaccine, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 30. Global Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 31. Global Poliomyelitis Vaccine Sales Share by Type (2018-2023)
    Table 32. Global Poliomyelitis Vaccine Sales Share by Type (2024-2029)
    Table 33. Global Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 34. Global Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 35. Global Poliomyelitis Vaccine Revenue Share by Type (2018-2023)
    Table 36. Global Poliomyelitis Vaccine Revenue Share by Type (2024-2029)
    Table 37. Poliomyelitis Vaccine Price by Type (2018-2023) & (USD/Unit)
    Table 38. Global Poliomyelitis Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
    Table 39. Global Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 40. Global Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 41. Global Poliomyelitis Vaccine Sales Share by Application (2018-2023)
    Table 42. Global Poliomyelitis Vaccine Sales Share by Application (2024-2029)
    Table 43. Global Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 44. Global Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 45. Global Poliomyelitis Vaccine Revenue Share by Application (2018-2023)
    Table 46. Global Poliomyelitis Vaccine Revenue Share by Application (2024-2029)
    Table 47. Poliomyelitis Vaccine Price by Application (2018-2023) & (USD/Unit)
    Table 48. Global Poliomyelitis Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
    Table 49. US & Canada Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 50. US & Canada Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 51. US & Canada Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 52. US & Canada Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 53. US & Canada Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 54. US & Canada Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 55. US & Canada Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 56. US & Canada Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 57. US & Canada Poliomyelitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 58. US & Canada Poliomyelitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 59. US & Canada Poliomyelitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 60. US & Canada Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
    Table 61. US & Canada Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
    Table 62. Europe Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 63. Europe Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 64. Europe Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 65. Europe Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 66. Europe Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 67. Europe Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 68. Europe Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 69. Europe Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 70. Europe Poliomyelitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 71. Europe Poliomyelitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 72. Europe Poliomyelitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 73. Europe Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
    Table 74. Europe Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
    Table 75. China Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 76. China Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 77. China Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 78. China Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 79. China Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 80. China Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 81. China Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 82. China Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 83. Asia Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 84. Asia Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 85. Asia Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 86. Asia Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 87. Asia Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 88. Asia Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 89. Asia Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 90. Asia Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 91. Asia Poliomyelitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 92. Asia Poliomyelitis Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 93. Asia Poliomyelitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 94. Asia Poliomyelitis Vaccine Sales by Region (2018-2023) & (K Units)
    Table 95. Asia Poliomyelitis Vaccine Sales by Region (2024-2029) & (K Units)
    Table 96. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
    Table 97. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
    Table 98. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
    Table 101. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
    Table 102. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 105. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
    Table 108. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
    Table 109. GSK Company Information
    Table 110. GSK Description and Major Businesses
    Table 111. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 112. GSK Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. GSK Recent Developments
    Table 114. Sanofi-Pasteur Company Information
    Table 115. Sanofi-Pasteur Description and Major Businesses
    Table 116. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 117. Sanofi-Pasteur Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Sanofi-Pasteur Recent Developments
    Table 119. Merck Company Information
    Table 120. Merck Description and Major Businesses
    Table 121. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 122. Merck Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Merck Recent Developments
    Table 124. Crucell Company Information
    Table 125. Crucell Description and Major Businesses
    Table 126. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 127. Crucell Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Crucell Recent Developments
    Table 129. China National Biotech Group Company Information
    Table 130. China National Biotech Group Description and Major Businesses
    Table 131. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 132. China National Biotech Group Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. China National Biotech Group Recent Developments
    Table 134. Eli Lilly Company Information
    Table 135. Eli Lilly Description and Major Businesses
    Table 136. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 137. Eli Lilly Poliomyelitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Eli Lilly Recent Developments
    Table 139. Key Raw Materials Lists
    Table 140. Raw Materials Key Suppliers Lists
    Table 141. Poliomyelitis Vaccine Distributors List
    Table 142. Poliomyelitis Vaccine Customers List
    Table 143. Poliomyelitis Vaccine Market Trends
    Table 144. Poliomyelitis Vaccine Market Drivers
    Table 145. Poliomyelitis Vaccine Market Challenges
    Table 146. Poliomyelitis Vaccine Market Restraints
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Poliomyelitis Vaccine Product Picture
    Figure 2. Global Poliomyelitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Poliomyelitis Vaccine Market Share by Type in 2022 & 2029
    Figure 4. Poliomyelitis Vaccine Ⅰ Product Picture
    Figure 5. Poliomyelitis Vaccine Ⅱ Product Picture
    Figure 6. Poliomyelitis Vaccine Ⅲ Product Picture
    Figure 7. Oral Poliomyelitis Vaccine Product Picture
    Figure 8. Global Poliomyelitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Poliomyelitis Vaccine Market Share by Application in 2022 & 2029
    Figure 10. VAPP
    Figure 11. VDPV
    Figure 12. Poliomyelitis Vaccine Report Years Considered
    Figure 13. Global Poliomyelitis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Poliomyelitis Vaccine Revenue 2018-2029 (US$ Million)
    Figure 15. Global Poliomyelitis Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 16. Global Poliomyelitis Vaccine Revenue Market Share by Region (2018-2029)
    Figure 17. Global Poliomyelitis Vaccine Sales 2018-2029 ((K Units)
    Figure 18. Global Poliomyelitis Vaccine Sales Market Share by Region (2018-2029)
    Figure 19. US & Canada Poliomyelitis Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 20. US & Canada Poliomyelitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 21. Europe Poliomyelitis Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 22. Europe Poliomyelitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 23. China Poliomyelitis Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 24. China Poliomyelitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 25. Asia (excluding China) Poliomyelitis Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 26. Asia (excluding China) Poliomyelitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 28. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 29. The Poliomyelitis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 30. The Top 5 and 10 Largest Manufacturers of Poliomyelitis Vaccine in the World: Market Share by Poliomyelitis Vaccine Revenue in 2022
    Figure 31. Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Global Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 33. Global Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 34. Global Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 35. Global Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 36. US & Canada Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 37. US & Canada Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 38. US & Canada Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 39. US & Canada Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 40. US & Canada Poliomyelitis Vaccine Revenue Share by Country (2018-2029)
    Figure 41. US & Canada Poliomyelitis Vaccine Sales Share by Country (2018-2029)
    Figure 42. U.S. Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 43. Canada Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 44. Europe Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 45. Europe Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 46. Europe Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 47. Europe Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 48. Europe Poliomyelitis Vaccine Revenue Share by Country (2018-2029)
    Figure 49. Europe Poliomyelitis Vaccine Sales Share by Country (2018-2029)
    Figure 50. Germany Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 51. France Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 52. U.K. Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 53. Italy Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 54. Russia Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 55. China Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 56. China Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 57. China Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 58. China Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 59. Asia Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 60. Asia Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 61. Asia Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 62. Asia Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 63. Asia Poliomyelitis Vaccine Revenue Share by Region (2018-2029)
    Figure 64. Asia Poliomyelitis Vaccine Sales Share by Region (2018-2029)
    Figure 65. Japan Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 66. South Korea Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 67. China Taiwan Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 68. Southeast Asia Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 69. India Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue Market Share by Type (2018-2029)
    Figure 72. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue Market Share by Application (2018-2029)
    Figure 74. Middle East, Africa and Latin America Poliomyelitis Vaccine Revenue Share by Country (2018-2029)
    Figure 75. Middle East, Africa and Latin America Poliomyelitis Vaccine Sales Share by Country (2018-2029)
    Figure 76. Brazil Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 77. Mexico Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 78. Turkey Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 79. Israel Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 80. GCC Countries Poliomyelitis Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 81. Poliomyelitis Vaccine Value Chain
    Figure 82. Poliomyelitis Vaccine Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed